As illustrated in Figure 4A, SLC35A2 expression in CRC tissues was significantly higher than that in adjacent normal tissues (p < 0.001), and SLC35A2 was found to be higher in tumor pathological stages III and IV than in stage I and stage II (p < 0.05, Figure 4B). This evidence concerns the gene SLC35A2 and neoplasm.